Should You Follow Hedge Funds Into These Healthcare Stocks?

#5. Biogen Inc (NASDAQ:BIIB)

First on our list of the top healthcare stocks among hedge funds is Biogen Inc (NASDAQ:BIIB), which made headlines last month after its first quarter results beat estimates. One of Biogen’s strengths is its $125,000 drug Spinraza, the only approved medication to treat muscular atrophy. Spinraza’s sales in the first quarter reached a whopping $47 million thanks to that hefty price tag. Biogen spun-off its blood diseases division in the first quarter, which now trades on the Nasdaq as Bioverativ Inc (NASDAQ:BIVV).

As of the end of the fourth quarter of last year, 76 hedge funds in our database were long Biogen Inc (NASDAQ:BIIB). Principal Global Investors’ Columbus Circle Investors owns 149,379 shares of Biogen as of the end of March 2017.

Chaikom/Shutterstock.com

Chaikom/Shutterstock.com

Follow Biogen Inc. (NASDAQ:BIIB)